Geoffrey Michael Glass

This profile gathers the share dealings of Geoffrey Michael Glass in Avadel Pharmaceuticals PLC, where the filings describe the role as board member. In total, 8 filings cover trades dated from 31 May 2022 to 12 February 2026.

On the market, this insider has only ever bought: 5 purchases, €540k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants.

The median purchase comes to €94k. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 12 February 2026, reports a transaction of €389k in Avadel Pharmaceuticals PLC. The most recent open-market purchase was published on 10 December 2024, 677 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.